Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort ascending
Job Title Site Location Division Business Functional Area Date Posted Sort ascending
Sales Representative (w/m/d), TA: Immunologie, Gebiet: Brandenburg Brandenburg (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Netzwerk Manager (m/w/d), Prostate Cancer, Saarland und Rheinland-Pfalz Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Quality Assurance Specialist Murcia Spain Operations Innovative Medicines Quality Oct 16, 2024
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 16, 2024
Spécialiste en marketing Montreal Canada International Innovative Medicines Marketing Oct 16, 2024
Risk & Assurance Manager Mumbai (Head Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Country ERC Head, India Mumbai (Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
External Workforce Management Process and Compliance Lead Prague Czech Republic People & Organization CTS Human Resources Oct 16, 2024
Manager, AI Operations Hyderabad (Office) India Operations CTS Marketing Oct 16, 2024
IT Program/ Project Manager Clinical Analytics Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 16, 2024
Tehnik (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 16, 2024
Pricing Manager Dublin (Country President Office (CPO)) Ireland International CTS Market Access Oct 16, 2024
Associate Director, Enterprise Architect Network Security Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 16, 2024
Human Resources Services Expert with German Prague Czech Republic People & Organization CTS Human Resources Oct 16, 2024
Comms & Engagement Manager Amsterdam Netherlands Corporate Affairs CTS Communications & Public Affairs Oct 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Oct 16, 2024
Director Science & Technology Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 16, 2024
H2R Services Expert Moscow (City) Russian Fed. People & Organization CTS Human Resources Oct 16, 2024
In-Market Brands Lead Jordan Jordan International Innovative Medicines BD&L & Strategic Planning Oct 16, 2024
Maintenance Specialist Ivrea Italy International Innovative Medicines Technical Operations Oct 16, 2024
Head of R&D Legal, R&D Transactions and Technical Research & Development Basel (City) Switzerland Legal Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Director, Development Unit Management Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 16, 2024
Senior Pharmareferent (m/w/d), Onkologie / Urologie / RLT, Gebiet: Rheinland-Pfalz & Saarland Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Associate Director, QC IT Solution Delivery Ljubljana Slovenia Operations CTS Technology Transformation Oct 16, 2024
Associate Director QC IT - LIMS Master Data Governance Ljubljana Slovenia Operations CTS Technology Transformation Oct 16, 2024
Commissioning & Qualification Engineer Warehouse & Logistics (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 16, 2024
Research Scientist, Cell Pharmacology - CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
PS&S Engagement Services Expert INSURGENTES Mexico People & Organization CTS Human Resources Oct 16, 2024
Manager, Value Stream Morris Plains USA Operations Innovative Medicines Technical Operations Oct 16, 2024
Senior Scientist I/II, Protein Engineering-REQ10019930 Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
Human Resources Specialist (5 Temporary roles -12 months) INSURGENTES Mexico People & Organization CTS Human Resources Oct 16, 2024
GCP Inspection Project Manager London (The Westworks) United Kingdom Development Innovative Medicines Quality Oct 16, 2024
Marketing Specialist Montreal Canada International Innovative Medicines Marketing Oct 16, 2024
Director of Applied AI Research | Data Science (Drug Discovery) Cambridge (USA) USA Biomedical Research Pharma Research Data and Digital Oct 16, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 16, 2024
Senior Expert Science & Technology, Analytical Development East Hanover USA Development Innovative Medicines Research & Development Oct 16, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Oct 16, 2024
Associate Director, Marketing Strategist - Immunology East Hanover USA US Innovative Medicines Marketing Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Field Product Specialist - Hue Vietnam Vietnam International Innovative Medicines Sales Oct 16, 2024
Manager Economic Modelling Hyderabad (Office) India Operations CTS Market Access Oct 16, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only